Vision Preference Value Scale and Patient Preferences in Choosing Therapy for Symptomatic Vitreomacular Interface Abnormality

被引:1
|
作者
Linz, Marguerite O. [1 ]
Bressler, Neil M. [1 ]
Chaikitmongkol, Voraporn [2 ]
Sivaprasad, Sobha [3 ]
Patikulsila, Diva [2 ]
Choovuthayakorn, Janejit [2 ]
Watanachai, Nawat [2 ]
Kunavisavut, Paradee [2 ]
Menon, Deepthy [3 ]
Tadarati, Mongkol [1 ,4 ]
Pacheco, Katia Delalibera [1 ,5 ]
Sanyal, Abanti [6 ]
Scott, Adrienne W. [1 ]
机构
[1] Johns Hopkins Univ, Retina Div, Wilmer Eye Inst, Sch Med, 600 N Wolfe St,Maumenee 719, Baltimore, MD 21287 USA
[2] Chiang Mai Univ, Retina Div, Dept Ophthalmol, Fac Med, Chiang Mai, Thailand
[3] Natl Inst Hlth, Med Retina Dept, Res Moorfields Biomed Res Ctr, London, England
[4] Rangsit Univ, Retina Div, Dept Ophthalmol, Rajavithi Hosp,Coll Med, Bangkok, Thailand
[5] Ctr Brasileiro Visao, Dept Retina, Brasilia, DF, Brazil
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
关键词
OCRIPLASMIN; TRACTION; METAANALYSIS; VITRECTOMY; RELEASE; EYE;
D O I
10.1001/jamaophthalmol.2018.1272
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
IMPORTANCE: While symptomatic vitreomacular interface abnormalities (VIAs) are common, assessment of vision preference values and treatment preferences of these may guide treatment recommendations by physicians and influence third-party payers. OBJECTIVE: To determine preference values that individuals with VIA assign to their visual state and preferences of potential treatments. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional one-time questionnaire study conducted between December 2015 and January 2017, 213 patients from tertiary care referral centers in Thailand, the United Kingdom, and the United States were studied. Patients with symptomatic VIA diagnosed within 1 year of data collection, visual acuity less than 20/20 OU, and symptoms ascribed to VIAs were included. Data were analyzed from January 2017 to November 2017. MAIN OUTCOMES AND MEASURES: The primary end points were overall mean preference value that individuals with VIA assigned to their visual state and patients' preferences for potential treatments. Preference values were graded on a scale from 0 to 1, with 0 indicating death and 1 indicating perfect health with perfect vision. RESULTS: Of the 213 included patients, 139 (65.3%) were women, and the mean (SD) age was 65.6 (7.7) years. Diagnoses included epiretinal membrane (n = 100 [46.9%]), macular hole (n = 99 [46.5%]), and vitreomacular traction (n = 14 [6.6%]). The mean (SD) vision preference value was 0.76 (0.15), without differences identified among the 3 VIA types. More participants were enthusiastic about vitrectomy (150 [71.1%]) compared with intravitreal injection (120 [56.9%]) (difference, 14.2%; 95% CI, 5.16-23.3; P = .002). Adjusted analyses showed enthusiasm for vitrectomy was associated with fellow eye visual acuity (odds ratio, 10.99; 95% CI, 2.01-59.97; P = .006) and better-seeing eye visual acuity (odds ratio, 0.03; 95% CI, 0.001-0.66; P = .03). Overall enthusiasm for treatment was associated with fellow eye visual acuity (odds ratio, 7.22; 95% CI, 1.29-40.40; P = .02). Overall, most participants (171 [81.0%]) were enthusiastic about surgery, injection, or both. CONCLUSIONS AND RELEVANCE: Study participants reported similar preference values among 3 types of VIAs. The data suggest that most patients with these conditions would be enthusiastic about undergoing vitrectomy or an injection to treat it, likely because of the condition's effect on visual functioning, although there may be a slight preference for vitrectomy at this time.
引用
收藏
页码:658 / 664
页数:7
相关论文
共 16 条
  • [1] Understanding therapy preferences of cancer patients with the use of therapy preference scale.
    Dhakal, Prajwal
    Wichman, Christopher S.
    Pozehl, Bunny J.
    Vose, Julie
    Bociek, Gregory
    Bhatt, Vijaya Raj
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Patient Preferences and Decisional Needs When Choosing a Treatment Approach for Pregnancy Hypertension: A Stated Preference Study
    Metcalfe, Rebecca K.
    Harrison, Mark
    Hutfield, Anna
    Lewisch, Mary
    Singer, Joel
    Magee, Laura A.
    Bansback, Nick
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2020, 36 (05) : 775 - 779
  • [3] Effect of vitreomacular interface abnormality on patient response to Intravitreal Anti-VEGF for treatment of Diabetic Macular Oedema in the clinical setting
    Maguire, Matthew James
    Laidlaw, Alistair
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [4] Therapy preference scale: A novel questionnaire to understand patients' preferences of cancer treatment.
    Bhatt, Vijaya Raj
    Dhakal, Prajwal
    Wichman, Christopher S.
    Pozehl, Bunny J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Development and validation of the Therapy Preference Scale to understand patients′ systemic cancer treatment preferences
    Bhatt, Vijaya Raj
    Dhakal, Prajwal
    Wichman, Christopher S.
    Pozehl, Bunny
    [J]. FUTURE ONCOLOGY, 2021, 17 (01) : 37 - 44
  • [6] The Role of Preference-Based Measures of Health States How Can We Use the Vision Preference Value Scale?
    Kymes, Steven M.
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2008, 126 (12) : 1765 - 1766
  • [7] Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money
    Al Said, Abir
    Cushen, Breda
    Costello, Richard W.
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2017, 8 (2-3) : 31 - 45
  • [8] Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study
    Gisbert, Javier P.
    Schreiber, Stefan
    Siegel, Corey A.
    Magro, Fernando
    Jus, Anna
    Whichello, Chiara
    Michaels-Igbokwe, Christine
    Heidenreich, Sebastian
    Oortwijn, Alessandra
    Vermeire, Severine
    [J]. INFLAMMATORY BOWEL DISEASES, 2024,
  • [9] Development the societal preference-based utility value set for the Patient Health Questionnaire depression scale in Hungary
    Balazs, P.
    Rencz, F.
    Brodszky, V.
    [J]. EUROPEAN PSYCHIATRY, 2022, 65 : S328 - S329
  • [10] A survey of patient informational preferences when choosing between medical and surgical therapy for ulcerative colitis: a sub-study from the DISCUSS project
    Lee, M. J.
    Folan, A. M.
    Baker, D. M.
    Blackwell, S.
    Wootton, R.
    Robinson, K.
    Sebastian, S.
    Brown, S. R.
    Jones, G. L.
    Lobo, A. J.
    [J]. COLORECTAL DISEASE, 2023, 25 (07) : 1479 - 1488